Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $2.20 and last traded at $2.02, with a volume of 105202 shares. The stock had previously closed at $2.12.
BioRestorative Therapies Stock Performance
The company has a market capitalization of $3.00 billion, a P/E ratio of -1.71 and a beta of 102.36. The firm’s fifty day moving average is $1.47 and its 200 day moving average is $1.53.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- How to Read Stock Charts for Beginners
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- 3 Fintech Stocks With Good 2021 Prospects
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What is the Euro STOXX 50 Index?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
